Bronchial Colonization With Fungi and Late Respiratory Acquired Pneumonia
Not Applicable
Completed
- Conditions
- Ventilator Acquired Pneumonia
- Interventions
- Procedure: biological samplingProcedure: sampling bloodProcedure: endotracheal aspiration
- Registration Number
- NCT01770015
- Lead Sponsor
- University Hospital, Grenoble
- Brief Summary
Ventilator acquired pneumonia (VAP) are severe nosocomial infections. On the other side, bronchial fungi colonization is commonly observed in ICU; therefore, the investigators propose to study the role of bronchial fungi colonization on the occurrence of VAP taking into account the immune status of the patient and the antibiotic and antifungal treatments he has received.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 213
Inclusion Criteria
- patient ventilated for at least 5 days
Exclusion Criteria
- invasive infection Candida sp defined by : candidemia, isolation of Candida from a normally sterile site, candida pneumoniae.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description ventilated patient biological sampling all patients underwent the same diagnostic test . cutaneous, rectal, nose and mouth swabs to identify potential fungi colonization. HLA DR antigen, cytokines (IL 6 and 10), B-glucan. fungi and bacteria endotracheal aspiration ventilated patient sampling blood all patients underwent the same diagnostic test . cutaneous, rectal, nose and mouth swabs to identify potential fungi colonization. HLA DR antigen, cytokines (IL 6 and 10), B-glucan. fungi and bacteria endotracheal aspiration ventilated patient endotracheal aspiration all patients underwent the same diagnostic test . cutaneous, rectal, nose and mouth swabs to identify potential fungi colonization. HLA DR antigen, cytokines (IL 6 and 10), B-glucan. fungi and bacteria endotracheal aspiration
- Primary Outcome Measures
Name Time Method Onset of a late ventilator acquired pneumonia (VAP) Participants will be followed for the duration of mechanical ventilation, an expected time frame that can go from 5 days to up to 8 weeks
- Secondary Outcome Measures
Name Time Method Onset of a pseudomonas aeruginosa associated VAP Participants will be followed for the duration of mechanical ventilation, an expected time frame that can go from 5 days to up to 8 weeks Onset of late ventilator associated pneumonia associated to staphylococcus aureus Participants will be followed for the duration of mechanical ventilation, an expected time frame that can go from 5 days to up to 8 weeks
Trial Locations
- Locations (2)
Hospital University Clermont Ferrand Gabriel Montpied
🇫🇷Clermont-Ferrand, France
University Hospital of Grenoble
🇫🇷Grenoble, France